Probiotics <i>Clostridium Butyricum</i> and <i>Bacillus Subtilis</i> Ameliorate Intestinal Tumorigenesis

Zhaofei Chen, Luoyan Ai, Jilin Wang, Linlin Ren, Yanan Yu, Jie Xu, Haoyan Chen, Jun Yu, Min Li, Wenxin Qin,

Future Microbiology · 2015 · 111 citations · 30 references

Concepts

Abstract

AIMS: To investigate the antitumor effects of probiotics Clostridium butyricum and Bacillus subtilis on colorectal cancer (CRC) progression. MATERIALS & METHODS: The effects of C. butyricum and B. subtilis on CRC cells were studied. Male C57BL/6 mice with 1,2-dimethylhydrazine dihydrochloride (DMH)-induced CRC were intervened by these two probiotics and the antitumor effects were examined by comparing the tumor incidence and detecting the inflammatory and immune-related markers. RESULTS & CONCLUSIONS: C. butyricum and B. subtilis inhibited the proliferation of CRC cells, caused cell cycle arrest and promoted apoptosis. In vivo, these two probiotics inhibited the development of DMH-induced CRC. The molecular mechanism involved reduced inflammation and improved immune homeostasis. This work establishes a basis for the protective role of probiotics B. subtilis and C. butyricum in intestinal tumorigenesis.

References

30